The Department of Health is offering the ‘Advancing Research on HIV-1 CNS Infection’ grant to investigate pathogenic mechanisms in HIV-1 induced Central Nervous System dysfunction while considering viral suppression and Antiretroviral therapy (ART). The grant aims to facilitate the development of therapeutic targets for preventing neurobehavioral and neurological co-morbidities in HIV-1 positive individuals. Both domestic and international research in basic and translational aspects are encouraged, along with the formation of collaborative research teams. Closing date for applications is on May 07, 2020.
Opportunity ID: 291028
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PA-17-100 |
| Funding Opportunity Title: | HIV-1 infection of the Central Nervous System (R01) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.242 — Mental Health Research Grants |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Jan 05, 2017 |
| Last Updated Date: | Nov 15, 2019 |
| Original Closing Date for Applications: | Jan 07, 2020 |
| Current Closing Date for Applications: | May 07, 2020 |
| Archive Date: | Jun 06, 2020 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) County governments State governments Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses City or township governments Independent school districts Public and State controlled institutions of higher education Special district governments For profit organizations other than small businesses Public housing authorities/Indian housing authorities |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) invites research grant applications focused on defining and understanding the pathogenic mechanisms involved in Human Immunodeficiency Virus (HIV)-1 induced CNS dysfunction, but within the context of viral suppression and Antiretroviral therapy (ART). The FOA further supports research to identify therapeutic targets against which treatments may be developed to prevent the neurobehavioral and neurological co-morbidities in HIV-1 infected individuals. Basic and translational research in domestic and international settings are of interest. Multidisciplinary research teams and collaborative alliances are encouraged but not required. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-17-100.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Extended Expiration Date as per the notice NOT-MH-20-007 | Nov 15, 2019 | |
| Jan 05, 2017 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PA-17-100 |
| Funding Opportunity Title: | HIV-1 infection of the Central Nervous System (R01) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.242 — Mental Health Research Grants |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Jan 05, 2017 |
| Last Updated Date: | Nov 15, 2019 |
| Original Closing Date for Applications: | Jan 07, 2020 |
| Current Closing Date for Applications: | May 07, 2020 |
| Archive Date: | Jun 06, 2020 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) County governments State governments Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses City or township governments Independent school districts Public and State controlled institutions of higher education Special district governments For profit organizations other than small businesses Public housing authorities/Indian housing authorities |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) invites research grant applications focused on defining and understanding the pathogenic mechanisms involved in Human Immunodeficiency Virus (HIV)-1 induced CNS dysfunction, but within the context of viral suppression and Antiretroviral therapy (ART). The FOA further supports research to identify therapeutic targets against which treatments may be developed to prevent the neurobehavioral and neurological co-morbidities in HIV-1 infected individuals. Basic and translational research in domestic and international settings are of interest. Multidisciplinary research teams and collaborative alliances are encouraged but not required. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-17-100.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PA-17-100 |
| Funding Opportunity Title: | HIV-1 infection of the Central Nervous System (R01) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.242 — Mental Health Research Grants |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jan 05, 2017 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Jan 07, 2020 |
| Archive Date: | Feb 07, 2020 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Independent school districts Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Public housing authorities/Indian housing authorities County governments Native American tribal governments (Federally recognized) Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) City or township governments Private institutions of higher education State governments Native American tribal organizations (other than Federally recognized tribal governments) Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) invites research grant applications focused on defining and understanding the pathogenic mechanisms involved in Human Immunodeficiency Virus (HIV)-1 induced CNS dysfunction, but within the context of viral suppression and Antiretroviral therapy (ART). The FOA further supports research to identify therapeutic targets against which treatments may be developed to prevent the neurobehavioral and neurological co-morbidities in HIV-1 infected individuals. Basic and translational research in domestic and international settings are of interest. Multidisciplinary research teams and collaborative alliances are encouraged but not required. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-17-100.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-D | Use for due dates on or before January 24, 2018 | PKG00230079 | Apr 07, 2017 | Jan 24, 2018 | View | |
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00235928 | Nov 08, 2017 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00259350 | Apr 07, 2017 | May 07, 2020 | View |
Package 1
Mandatory forms
291028 RR_SF424_2_0-2.0.pdf
291028 PHS398_CoverPageSupplement_3_0-3.0.pdf
291028 RR_OtherProjectInfo_1_3-1.3.pdf
291028 PerformanceSite_2_0-2.0.pdf
291028 RR_KeyPersonExpanded_2_0-2.0.pdf
291028 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
291028 RR_Budget_1_3-1.3.pdf
291028 RR_SubawardBudget30_1_3-1.3.pdf
291028 PHS398_ModularBudget_1_2-1.2.pdf
291028 PHS_Inclusion_Enrollment_Report-1.0.pdf
291028 PHS_AssignmentRequestForm-1.0.pdf
Package 2
Mandatory forms
291028 RR_SF424_2_0-2.0.pdf
291028 PHS398_CoverPageSupplement_4_0-4.0.pdf
291028 RR_OtherProjectInfo_1_4-1.4.pdf
291028 PerformanceSite_2_0-2.0.pdf
291028 RR_KeyPersonExpanded_2_0-2.0.pdf
291028 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
291028 RR_Budget_1_4-1.4.pdf
291028 RR_SubawardBudget30_1_4-1.4.pdf
291028 PHS398_ModularBudget_1_2-1.2.pdf
291028 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 3
Mandatory forms
291028 RR_SF424_2_0-2.0.pdf
291028 PHS398_CoverPageSupplement_5_0-5.0.pdf
291028 RR_OtherProjectInfo_1_4-1.4.pdf
291028 PerformanceSite_2_0-2.0.pdf
291028 RR_KeyPersonExpanded_2_0-2.0.pdf
291028 PHS398_ResearchPlan_4_0-4.0.pdf
291028 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
291028 RR_Budget_1_4-1.4.pdf
291028 RR_SubawardBudget30_1_4-1.4.pdf
291028 PHS398_ModularBudget_1_2-1.2.pdf
291028 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
